KNG1 and acute pancreatitis: If bradykinin turns out be central to the development of COVID-19 as well as acute pancreatitis, and treatments to reduce bradykinin levels or its effects are found effective in combatting these often devastating diseases, then this will be a truly remarkable story, in which a molecule that for a long time was overshadowed by histamine, and thought by many to be of relatively minor interest, suddenly takes center stage in the fight against a major pandemic.